Magmedi

Magnesium, the active ingredient in Magmedi, is a mineral supplement presented as an oral tablet for oral use. It helps correct magnesium deficiency, supports normal muscle and nerve function, and contributes to electrolyte balance in adults and children when needed.

GNH USA supplies Magmedi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magmedi is a mineral supplement that addresses conditions related to low magnesium levels and electrolyte disturbances. - Magnesium deficiency: restores normal serum magnesium concentrations and supports metabolic processes. - Muscle cramps: reduces the frequency and intensity of involuntary muscle contractions. - Electrolyte balance: assists in maintaining proper cellular electrolyte homeostasis during increased physiological stress.

Magmedi is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Diarrhea: loose stools occurring after oral intake. - Abdominal discomfort: mild cramping or bloating. - Nausea: feeling of queasiness without vomiting. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Hypermagnesemia: elevated blood magnesium levels causing weakness, low blood pressure, or cardiac arrhythmia. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Persistent vomiting: may lead to dehydration and electrolyte imbalance. - Muscle weakness: unusual loss of strength not related to underlying condition.

Before using Magmedi, consider the following safety measures. - Renal impairment: assess kidney function as reduced clearance can increase magnesium levels. - Concomitant medications: review drugs that affect magnesium absorption or excretion. - Gastrointestinal disorders: monitor for worsening symptoms in conditions like ulcerative colitis. - Pregnancy and lactation: use only if prescribed after risk‑benefit evaluation. - Storage: Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Magmedi may interact with other medicines; monitoring is advised.

Major Interactions (Avoid): - Tetracycline antibiotics: concurrent use can markedly reduce magnesium absorption. - Fluoroquinolone antibiotics: may form insoluble complexes, decreasing effectiveness of both agents. - Bisphosphonates: magnesium can impair oral bisphosphonate absorption, reducing bone‑protective benefits.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase urinary magnesium loss, requiring dosage adjustment. - ACE inhibitors or ARBs: combined use can potentiate hypermagnesemia, especially in renal dysfunction. - Calcium channel blockers: concurrent high magnesium may enhance hypotensive effects.